Developing Yeast Models of Human Neurodegenerative Disorders

Methods in Molecular Biology

Volumn 793, Issue , 2011, Pages 113-127

  Ocampo, Alejandro ^a   Barrientos, Antoni ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Neurodegeneration; Protein aggregation; Proteinophaties; Yeast model

Indexed keywords

FLUORESCENT DYE; HYBRID PROTEIN;

ARTICLE; BIOLOGICAL MODEL; CELL LINE; CHEMISTRY; CYTOLOGY; DEGENERATIVE DISEASE; FLUORESCENCE MICROSCOPY; GENETIC TRANSFORMATION; GENETICS; HUMAN; METABOLISM; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; SACCHAROMYCES CEREVISIAE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; FLUORESCENT DYES; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE; TRANSFORMATION, GENETIC;

ANIMALIA; SACCHAROMYCES CEREVISIAE;

EID: 80054764778     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-328-8_8     Document Type: Chapter

References (14)

1. Botstein, D. (1991) Why yeast Hosp. Pract. (Off. Ed.) 26, 157–61.
2. Miller-Fleming, L., Giorgini, F., and Outeiro, T. F. (2008) Yeast as a model for studying human neurodegenerative disorders Biotechnol. J. 3, 325–38.
3. Khurana, V., and Lindquist, S. Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker’s yeast? Nat. Rev. Neurosci. 11, 436–49.
4. Middendorp, O., Luthi, U., Hausch, F., and Barberis, A. (2004) Searching for the most effective screening system to identify cell-active inhibitors of beta-secretase Biol. Chem. 385, 481–5.
5. Caine, J., Sankovich, S., Antony, H., Waddington, L., Macreadie, P., Varghese, J., and Macreadie, I. (2007) Alzheimer’s Abeta fused to green fluorescent protein induces growth stress and a heat shock response FEMS Yeast Res. 7, 1230–6.
6. Krobitsch, S., and Lindquist, S. (2000) Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins Proc. Natl. Acad. Sci. USA 97, 1589–94.
7. Meriin, A. B., Zhang, X., He, X., Newnam, G. P., Chernoff, Y. O., and Sherman, M. Y. (2002) Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1 J. Cell Biol. 157, 997–1004. Epub 10 June 2002.
8. Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C., and Muchowski, P. J. (2005) A genomic screen in yeast implicates kynurenine 3-monooxyge-nase as a therapeutic target for Huntington disease Nat. Genet. 37, 526–31.
9. Outeiro, T. F., and Lindquist, S. (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology Science 302, 1772–5.
10. Chen, Q., Thorpe, J., and Keller, J. N. (2005) Alpha-synuclein alters proteasome function, protein synthesis, and stationary phase viability J. Biol. Chem. 280, 30009–17. Epub 7 June 2005.
11. Dixon, C., Mathias, N., Zweig, R. M., Davis, D. A., and Gross, D. S. (2005) Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast Genetics 170, 47–59.
12. Johnson, B. S., McCaffery, J. M., Lindquist, S., and Gitler, A. D. (2008) A yeast TDP-43 pro-teinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity Proc. Natl. Acad. Sci. USA 105, 6439–44.
13. Myers, A. M., Pape, L. K., and Tzagoloff, A. (1985) Mitochondrial protein synthesis is required for maintenance of intact mitochondrial genomes in Saccharomyces cerevisiae EMBO J. 4, 2087–92.
14. Ocampo, A., and Barrientos, A. (2008) From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders Biotechniques 45, vii–xiv.